AptaBio Therapeutics Inc. (293780.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.3x

Market Cap

KRW 178.16B

MomentumView details →

1D Return

+4.91%

YTD Return

−30.91%

RSI (14)

59.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.3x

Market Cap

KRW 178.16B

RSI (14)

59.6

MomentumView details →

1D Return

+4.91%

YTD Return

−30.91%

ProfitabilityView details →

Gross Margin

43.25%

Net Margin

−312.85%

EBITDA Margin

−481.75%

ROE (TTM)

−35.23%

ROA (TTM)

−27.34%

Asset Turnover

0.09x

GrowthView details →

Revenue YoY

+52.90%

EPS YoY

+47.25%

FCF YoY

−16.48%

Revenue CAGR 3Y

+324.45%

EPS CAGR 3Y

+52.31%

EBITDA YoY

−48.17%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.12x

Current Ratio

2.54x

Quick Ratio

2.47x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.75B

Net Income (TTM)

−14.87B

Op. CF (TTM)

−17.37B

Latest newsMore news →

No recent news for 293780.KQ.

Similar companies

FutureChem Co.,Ltd220100.KQ JW Lifescience Corporation234080.KS REYON Pharmaceutical Co., Ltd.102460.KS Daewon Pharmaceutical Co., Ltd.003220.KS Whan In Pharm Co.,Ltd.016580.KS BNC Korea Co., Ltd.256840.KQ Find similar companies →

Latest newsMore news →

No recent news for 293780.KQ.